Business
WELL Health Delivers Record Q1-2026 with Canadian Clinics Run Rate Exceeding $500M and Revenue Up 25% to $368M
WELL achieved quarterly revenues of $368.3 million in Q1-2026, an increase of 25% as compared to ...
About this update from Well Health Technologies Corp.
[{"type":"text","content":"WELL Health Delivers Record Q1-2026 with Canadian Clinics Run Rate Exceeding $500M and Revenue Up 25% to $368MWELL achieved quarterly revenues of $368.3 million in Q1-2026, an increase of 25% as compared to Q1-2025 driven by organic growth, acquisitions and the inclusion of HEALWELL results in WELL's consolidated financial reporting.WELL achieved Adjusted EBITDA(1) of $43.1 million in Q1-2026, an increase of 56% as compared to Q1-2025, representing an Adjusted EBITDA Margin(1) of 12%.Canadian Patient Services revenues(4) increased by 30% to $130.3 million and Adjusted EBITDA(1) increased by 28% to $17.0 million in Q1-2026, driven by acquisitions and organic growth of 8% for the Canadian Patient Services business.WELL recorded a total of 1.9 million patient visits in Q1-2026, an increase of 17% as compared to Q1-2025, driven by 33% YoY growth of Canadian patient services visits and strong organic growth of 13% in Canada.WELL reaffirms its previously provided guidance for annual revenue between $1.55 billion to $1.65 billion with Adjusted EBITDA(1) in the range of $175 million to $185 million.Vancouver, British Columbia--(Newsfile Corp. - May 7, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the \"Company\" or \"WELL\"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its interim consolidated financial results for the quarter ended March 31, 2026.Hamed Shahbazi, Chairman and CEO of WELL commented, \"We are very pleased to report a strong start to 2026, with solid first quarter performance that saw our revenue run rate approach the $1.5 billion per year mark. Our Canadian clinics business continued to be a key driver of growth, achieving a revenue run rate of over half a billion dollars per year while delivering 30% year-over-year revenue growth, including 13% organic growth(3). Our broader WELL Canada platform, inclusive of WELLSTAR and CYBERWELL, also delivered strong results with 26% year-over-year revenue growth and 15% growth in Adjusted EBITDA(1), with WELLSTAR continuing to deliver Rule of 40 performance. We delivered record patient visits in the quarter, with Canadian visits growing 33% year-over-year, reflecting both our acquisition discipline and the underlying d...